Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
INTRODUCTION: Low-dose hydrocortisone treatment is widely accepted therapy for the treatment of vasopressor-dependent septic shock. The question of whether corticosteroids should be given to septic shock patients by continuous or by bolus infusion is still unanswered. Hydrocortisone induces hyperglycemia and it is possible that continuous hydrocortisone infusion would reduce the fluctuations in blood glucose levels and that tight blood glucose control could be better achieved with this approach. METHODS: In this prospective randomized study, we compared the blood glucose profiles, insulin requirements, amount of nursing workload needed, and shock reversal in 48 septic shock patients who received hydrocortisone treatment either by bolus or by continuous infusion with equivalent dose (200 mg/day). Duration of hydrocortisone treatment was five days. RESULTS: The mean blood glucose levels were similar in the two groups, but the number of hyperglycemic episodes was significantly higher in those patients who received bolus therapy (15.7 +/- 8.5 versus 10.5 +/- 8.6 episodes per patient, p = 0.039). Also, more changes in insulin infusion rate were needed to maintain strict normoglycemia in the bolus group (4.7 +/- 2.2 versus 3.4 +/- 1.9 adjustments per patient per day, p = 0.038). Hypoglycemic episodes were rare in both groups. No difference was seen in shock reversal. CONCLUSION: Strict normoglycemia is more easily achieved if the hydrocortisone therapy is given to septic shock patients by continuous infusion. This approach also reduces nursing workload needed to maintain tight blood glucose control.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“while supraphysiologic peaks might come with adverse side effects, as previously shown in the context of sepsis with an increased rate of hyperglycemic episodes (22).”
From Prevention of adrenal crisis: cortisol responses to major stress compared to stress dose hydrocortisone delivery (2020) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
APACHE II: A severity of disease classification system
KNAUS, W. A., DRAPER, E. A., WAGNER, D. P., & ZIMMERMAN, J. E. (1985) · Critical Care Medicine · doi:10.1097/00003246-198510000-00009 · Cited by 13,664
APACHE II-A Severity of Disease Classification System: Reply
Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1986) · Critical Care Medicine · doi:10.1097/00003246-198608000-00028 · Cited by 13,376 · cited 1×
“APACHE (Acute Physiology and Chronic Health Evaluation) II score [15] and SAPS (Simplified Acute Physiology Score) II [16] were calculated and the severity of organ dysfunction was assessed using SOFA (Sepsis-related Organ Failure Assessment) score [17] at the time of ICU admission.”
MethodBone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773 · cited 1×
“APACHE (Acute Physiology and Chronic Health Evaluation) II score [15] and SAPS (Simplified Acute Physiology Score) II [16] were calculated and the severity of organ dysfunction was assessed using SOFA (Sepsis-related Organ Failure Assessment) score [17] at the time of ICU admission.”
MethodAPACHE II: a severity of disease classification system.
Knaus, W. A., Draper, E. S., Wagner, D. P., & Zimmerman, J. E. (1985) · PubMed · Cited by 6,034
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock
Dellinger, R. P., Carlet, J. M., Masur, H., Gerlach, H., Calandra, T., Cohen, J., Gea-Banacloche, J., Keh, D., Marshall, J. C., Parker, M. M., et al. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2210-z · Cited by 3,321
Annane, D. (2002) · JAMA · doi:10.1001/jama.288.7.862 · Cited by 3,087
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
De Jonghe, B. (2002) · JAMA · doi:10.1001/jama.288.22.2859 · Cited by 1,516 · cited 1×
“In addition, corticosteroids may increase the risk of critical illness polyneuropathy and myopathy, and therefore the use of corticosteroids may be associated with protracted weaning from mechanical ventilation [7,11].”
BackgroundKrinsley, J. S. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1471 · Cited by 1,165 · cited 1×
“Impaired glycemic control has been associated with increased mortality in a heterogeneous population of critically ill patients [8], and van den Berghe and coworkers [9] showed that”
BackgroundGlucose Control and Mortality in Critically Ill Patients
Finney, S. J. (2003) · JAMA · doi:10.1001/jama.290.15.2041 · Cited by 1,055
Briegel, J., Forst, H., Haller, M., Schelling, G., Kilger, E., Kuprat, G., Hemmer, B., Hummel, T., Lenhart, A., Heyduck, M., et al. (1999) · Critical Care Medicine · doi:10.1097/00003246-199904000-00025 · Cited by 889 · cited 1×
“In prospective randomized trials, hydrocortisone therapy has shown a significant effect in septic shock reversal [2, 3 ], and in one large prospective study, a treatment with a hydrocortisone-fludrocortisone combination also reduced mortality in the subgroup of patients who had a poor adrenal response in the adrenocor…”
BackgroundReversal of late septic shock with supraphysiologic doses of hydrocortisone
Bollaert, P.-E., Charpentier, C., Levy, B., Debouverie, M., Audibert, G., & Larcan, A. (1998) · Critical Care Medicine · doi:10.1097/00003246-199804000-00010 · Cited by 872
Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis
Annane, D., Bellissant, E., Bollaert, P. E., Briegel, J., Keh, D., & Kupfer, Y. (2004) · BMJ · doi:10.1136/bmj.38181.482222.55 · Cited by 443
Cardiovascular management of septic shock
Dellinger, R. P. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000057403.73299.a6 · Cited by 369 · cited 1×
“Hydrocortisone treatment was started according to clinical judgment when patients required high-dose or increasing norepinephrine support [18].”
MethodOppert, M., Schindler, R., Husung, C., Offermann, K., Gräf, K.-J., Boenisch, O., Barckow, D., Frei, U., & Eckardt, K.-U. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000186370.78639.23 · Cited by 327 · cited 1×
“So far, no studies have compared bolus versus continuous hydrocortisone infusion regimen and their effects to blood glucose profiles in septic shock [2,13].”
BackgroundPredisposing factors for hypoglycemia in the intensive care unit*
Vriesendorp, T. M., van Santen, S., DeVries, J. H., de Jonge, E., Rosendaal, F. R., Schultz, M. J., & Hoekstra, J. B. L. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000194536.89694.06 · Cited by 282 · cited 1×
“In severely ill ICU patients, this risk seems to be higher than in postoperative patients, and patients with sepsis are especially vulnerable to hypoglycemia [10,20,21].”
BackgroundReply to Zandstra and van der Voort
Dellinger, R. P., Gerlach, H., & Carlet, J. (2004) · Intensive Care Medicine · doi:10.1007/s00134-004-2398-y · Cited by 247
Critical illness polyneuropathy and myopathy in patients with acute respiratory distress syndrome*
Bercker, S., Weber-Carstens, S., Deja, M., Grimm, C., Wolf, S., Behse, F., Busch, T., Falke, K. J., & Kaisers, U. (2005) · Critical Care Medicine · doi:10.1097/01.ccm.0000157969.46388.a2 · Cited by 194 · cited 1×
“Prolonged hyperglycemia is one possible pathophysiologic mechanism behind these complications [12].”
BackgroundUse of corticosteroid therapy in patients with sepsis and septic shock: An evidence-based review
Keh, D., & Sprung, C. L. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142983.15421.11 · Cited by 121 · cited 2×
“Alternatively, hydrocortisone may be administered by continuous infusion [5].”
BackgroundAdjunctive therapies in sepsis: An evidence-based review
Cariou, A., Vinsonneau, C., & Dhainaut, J.-F. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000142910.01076.a5 · Cited by 68 · cited 1×
“Hyperglycemia was defined as a blood glucose level of more than 7 mmol/l (126 mg/dl) and severe hyperglycemia as a blood glucose level of more than 8.3 mmol/l (150 mg/dl) [ 19 ].”
BackgroundInfluentialCorticosteroids influence the mortality and morbidity of acute critical illness
Rady, M. Y., Johnson, D. J., Patel, B., Larson, J., & Helmers, R. (2006) · Critical Care · doi:10.1186/cc4971 · Cited by 48 · cited 2×
“It is possible that corticosteroid treatment may induce hyperglycemia and that the frequency of insulin use may increase with corticosteroid exposure [7].”
BackgroundNutritional papers in ICU patients: what lies between the lines?
Preiser, J., Chioléro, R. L., & Wernerman, J. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1581-2 · Cited by 30 · cited 1×
“The standardization of nutritional support has also been difficult in other trials concerning critically ill patients [23].”
Cited by
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Marik, P. E., Pastores, S. M., Annane, D., Meduri, G. U., Sprung, C. L., Arlt, W., Keh, D., Briegel, J., Beishuizen, A., Dimopoulou, I., et al. (2008) · Critical Care Medicine · doi:10.1097/ccm.0b013e31817603ba · Cited by 912
Corticosteroids in the Treatment of Severe Sepsis and Septic Shock in Adults: A Systematic Review
Annane, D., Bellissant, E., Bollaert, P.-E., Briegel, J., Confalonieri, M., De Gaudio, R., Keh, D., Kupfer, Y., Oppert, M., & Meduri, G. U. (2009) · JAMA · doi:10.1001/jama.2009.815 · Cited by 561
“One randomized controlled trial suggested that continuous hydrocortisone infusion, compared with bolus administration, might result in fewer episodes of hyperglycemia.(60) The recent update of the Surviving Sepsis Campaign suggested that intravenous hydrocortisone should be given only to adult septic shock patients af…”
Critical Illness-Related Corticosteroid Insufficiency
Marik, P. E. (2009) · Chest · doi:10.1378/chest.08-1149 · Cited by 299
Keh, D., Trips, E., Marx, G., Wirtz, S. P., Abduljawwad, E., Bercker, S., Bogatsch, H., Briegel, J., Engel, C., Gerlach, H., et al. (2016) · JAMA · doi:10.1001/jama.2016.14799 · Cited by 277
“Hospital 25 (16-40) 26 (16-46) 26 (16-43) .”
Metadata
- Authors
- Loisa, P., Parviainen, I., Tenhunen, J., Hovilehto, S., & Ruokonen, E.
- Affiliations
- Päijät-Hämeen Keskussairaala (FI)
- Kuopio University Hospital (FI)
- Tampere University Hospital (FI)
- South Karelia Central Hospital (FI)
- Corresponding author
- Loisa, Pekka
- ORCID
- Tenhunen, Jyrki
- Venue
- Critical Care
- Published
- 2007-02-16
- Volume
- 11
- Issue
- 1
- Pages
- R21-R21
- ISSN
- 1364-8535 (ISSN-L)
- PMC
- PMC2151907
- OpenAlex
- W1954574580
- Cited by
- 95
- References
- 27
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 4 · 2020: 5 · 2019: 11 · 2018: 6 · 2017: 2 · 2016: 2 · 2015: 5 · 2014: 6 · 2013: 3 · 2012: 3
- FWCI
- 4.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Critical Care (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Tays
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- septic shock, cortisol, continuous infusion, bolus infusion, glycemic control, hyperglycemia, insulin requirement, nursing workload, corticosteroid therapy
- MeSH terms
- Anti-Inflammatory Agents, Blood Glucose, Humans, Hydrocortisone, Hyperglycemia, Infusions, Intravenous, Injections, Intravenous, Middle Aged, Prospective Studies, Shock, Septic, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.